This quarterly data report details industry-specific statistics compiled from hundreds of cell therapy, gene therapy, tissue engineering, and other regenerative medicine therapeutic developers worldwide, including total financings, partnerships and other deals, clinical trial information, key clinical data events, and ARM’s current strategic priorities.
Regenerative Medicine Companies
Worldwide, Including Gene and
Cell Therapies, and Tissue Engineering
Therapeutic Developers
Increase from Q3 2017
Increase year-over-year
$10.7B Raised YTD 2018
Increase from Q3 2017
Increase year-over-year
$7.8B raised YTD 2018
Increase from Q3 2017
Increase year-over-year
$6.0B raised YTD 2018
Decrease from Q3 2017
Increase year-over-year
$786M raised YTD 2018
1003
Clinical trials underway
worldwide by the end of Q3 2018
330
580
93
